Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 126

Results For "ITU"

1813 News Found

KIMS Hospitals sign MoU with Dr Raj Nagarkar to set up a hospital at Nashik
Hospitals | May 15, 2022

KIMS Hospitals sign MoU with Dr Raj Nagarkar to set up a hospital at Nashik

The new hospital is expected to open by March'24


Merck KGaA first quarter earnings grows on higher volumes, margins
News | May 15, 2022

Merck KGaA first quarter earnings grows on higher volumes, margins

Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter


Jawed Zia appointed CEO of Cadila Pharmaceuticals Domestic Prescription Business
People | May 14, 2022

Jawed Zia appointed CEO of Cadila Pharmaceuticals Domestic Prescription Business

A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business


WHO and MPP announce agreement with NIH for Covid-19 health technologies
Public Health | May 13, 2022

WHO and MPP announce agreement with NIH for Covid-19 health technologies

The licences will allow manufacturers from around the world to work with MPP and C-TAP to make these technologies accessible to people living in low- and middle-income countries


Ultivue announces AI Partner Ecosystem to accelerate research in translational medicine
Biotech | May 13, 2022

Ultivue announces AI Partner Ecosystem to accelerate research in translational medicine

Image and data analysis of rich spatial information from mIF images can accelerate tissue biomarker discovery and validation


First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial
Biotech | May 12, 2022

First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial

CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng


USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19
Drug Approval | May 12, 2022

USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19

Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19


‘One Step’ portal to provide information on medical tourism: Dr Mansukh Mandaviya
News | May 12, 2022

‘One Step’ portal to provide information on medical tourism: Dr Mansukh Mandaviya

“We are committed to making India a global medical value hub by further strengthening our traditional medicine industry and boosting 'Heal in India' & 'Heal by India'


Aurobindo Pharma Ltd gets 6 observations from USFDA for Unit VII
News | May 11, 2022

Aurobindo Pharma Ltd gets 6 observations from USFDA for Unit VII

The unit is an oral manufacturing facility at Jedcherla, Hyderabad


Medikabazaar conducts successful trial of medical supplies through drone delivery
Startup | May 11, 2022

Medikabazaar conducts successful trial of medical supplies through drone delivery

The company intends to begin using drones to make deliveries of critical and emergency medical supplies, vaccines, and lifesaving drugs after getting the prerequisite regulatory approvals